The IMBM Lab focuses on developing biomaterials that can modulate cell responses and create biomimetic, controllable microenvironments for applications in medicine and bioengineering. Central to our approach are self-assembling peptide-based systems, which are molecularly designed to display complex and diverse bioactive chemical motifs.
Our work integrates three main research areas: (1) uncovering the fundamental principles that govern self-assembly and biological function in peptide-based materials, (2) using this knowledge to inform the rational design of multifunctional, tunable biomaterials, and (3) translating these materials into therapeutic and biomedical applications in cancer immunotherapy, cell manufacturing, regenerative medicine, and tissue engineering. By leveraging the power of programmable molecular self-assembly, our goal is to engineer next-generation biomaterials that not only support but actively instruct cell behavior.